{"id":648092,"date":"2023-04-19T19:00:01","date_gmt":"2023-04-19T19:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=648092"},"modified":"2023-04-19T19:00:01","modified_gmt":"2023-04-19T19:00:01","slug":"cystinosis-market-is-projected-to-grow-during-the-forecast-period-20222032-estimates-delveinsight-key-companies-eloxx-avrobio-leadiant-nacuity-pharma-recordati-birch-therapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cystinosis-market-is-projected-to-grow-during-the-forecast-period-20222032-estimates-delveinsight-key-companies-eloxx-avrobio-leadiant-nacuity-pharma-recordati-birch-therapeutics_648092.html","title":{"rendered":"Cystinosis Market is Projected to Grow During the Forecast Period (2022-2032) – Estimates DelveInsight | Key Companies – Eloxx, AVROBIO, Leadiant, Nacuity Pharma, Recordati, Birch Therapeutics"},"content":{"rendered":"
\n
\"Cystinosis<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Cystinosis Market size in the 7MM was USD 174 million (approx.) in 2021, which is expected to grow by 2032. Some of the key factors, such as the rising prevalent population of Cystinosis patients in the 7MM, rising awareness of Cystinosis, and the launch of new therapies, are anticipated to drive the market growth.<\/div>\n

DelveInsight’s “Cystinosis Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Cystinosis market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/p>\n

The Cystinosis market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Cystinosis<\/p>\n

Cystinosis: An Overview<\/strong><\/p>\n

Cystinosis is a disease caused by an abnormal buildup of a particular amino acid called cystine. It is a rare but serious disease with a lifelong impact and can affect many parts of the body. There are three types of cystinosis, depending on when symptoms first appear (known as onset): infantile (early-onset) cystinosis, late childhood or adolescent (late-onset) cystinosis, and adult cystinosis.<\/p>\n

Cystinosis is a recessive genetic disorder, and patients must receive an abnormal copy of the cystinosin gene from each parent to develop the disease. In people with cystinosis, a buildup of cystine can lead to the formation of crystals.<\/p>\n

Cystinosis is caused by bi-allelic mutations in the CTNS gene (17p13.2) encoding cystinosin, a lysosomal cystine-proton co-transporter. Consequently, cystine accumulates in the lysosomes of affected cells and forms crystals in low lysosomal pH. <\/strong><\/em><\/p>\n

Cystinosis Market Key Facts<\/strong><\/p>\n